HCA Healthcare’s stock rose modestly by 1.5% as volume growth and Medicaid supplemental payments partly offset financial pressure from a significant payer mix shift driven by a surge in uninsured patients after the expiration of enhanced premium tax credits.
HCA Healthcare delivered robust third-quarter results with a 42% increase in adjusted diluted earnings per share and a 9.6% revenue growth, driven by volume expansion and improved payer mix.